fbpx
QQQ
+ 0.00
304.28
+ 0%
DIA
+ 0.00
300.01
+ 0%
SPY
+ 0.00
366.67
+ 0%
TLT
+ 0.00
157.51
+ 0%
GLD
-0.02
172.84
-0.01%

Real Brands Closes Merger With Canadian American Standard Hemp

October 27, 2020 12:39 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Real Brands Inc. (OTCPK: RLBD) confirmed Tuesday, it has finalized the acquisition of Canadian American Standard Hemp Inc.

Under the reverse merger deal, CASH shareholders obtained majority control of Real Brands.

CASH agreed to continue to operate as Real Brands’ wholly-owned subsidiary. In addition, Real Brands would maintain the name and trading symbol.

The entity’s new headquarters will be located at 12 Humbert St., in North Providence, Rhode Island.

The strategic merger joins hemp-derived CBD extraction, wholesale CBD oils/isolates, CBD product formulations, and consumer brands into the new publicly traded entity, as per press release.

In addition, Real Brands tapped Thom Kidrin to helm the company, replacing former Real Brands CEO Jerry Pearring.

“This strategic merger with Real Brands is designed to drive increased shareholder value and provide the public with an opportunity to participate in the growing global hemp-derived CBD market,” Kidrin stated. “With access to the capital markets now, we anticipate it will be easier and faster to fund our next phases of expected growth.”

Meantime, over the last few months, some merger deals in the industry were canceled, including Aphria’s (TSE: APHA) (NASDAQ:APHA) and Aurora Cannabis’ (TSE: ACB) (NYSE:ACB) talks to merge.

The $3.5 billion deal was suspended in July after two parties disagreed on board composition, as Bloomberg News reported.

Posted-In:

Cannabis M&A News Markets

Related Articles

Emerald Health Pharmaceuticals To Raise $17M Via New Reg A+ Round

Emerald Health Pharmaceuticals Inc. (EHP) is launching a new financing round under its Regulation A offering. The round will open on Monday, Dec. 7, and expire on Mar. 28, 2021, or upon raising roughly $17 million, which is the maximum amount to be raised, the Sand Diego biotech company said. read more

Gaby Buys Mankind Cannabis Dispensary For $36.5M, Confirms $8.5M Private Placement

Shares of GABY Inc. (OTCQB: GABLF) are trading up almost 6% on Thursday afternoon, after the cannabis company announced a merger with Mankind Dispensary, one of the first licensed dispensaries in California. read more

420 Investor: 'This Is The Most Excited I've Ever Been' In Cannabis

Alan Brochstein, author of 420 Investor and founding partner of New Cannabis Ventures, says the recent political momentum behind the cannabis legalization push in the US — and the resulting rebound in cannabis stocks since the U.S. election — has him feeling extremely optimistic about the industry's future. read more

Canadian Cannabis Stocks Are Becoming Less Desirable Investments, Data Suggests

Cannabis stocks have taken a hit since Election Day, Nov. 3. The latest Hifyre cannabis sales data out of Canada suggests some concerning trends in the market. The Numbers: Month-over-month, Canadian retail cannabis sales were up just 4% in October and down 3% in November, Hifyre estimates. read more

PreMarket Prep Stock Of The Day: GW Pharmaceuticals

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session. read more